| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Blum Robert I President & CEO | Sale | -7,500 | -1.91%385,330 | $70.46 | $528,450 | View SEC filing | |
| 2026-06-09 | Malik Fady Ibraham EVP Research & Development | Sale | -3,500 | -2.22%153,902 | $67.98 | $237,930 | View SEC filing | |
| 2026-06-01 | Kaye Edward M. MD Director | Sale | -2,933 | -22.19%10,283 | $76.09 | $223,172 | View SEC filing | |
| 2026-06-01 | Callos Andrew EVP, Chief Commercial Officer | Sale | -15,000 | -20.39%58,555 | $74.08 | $1,111,200 | View SEC filing | |
| 2026-06-01 | PARSHALL B LYNNE Director | Sale | -5,000 | -24.06%15,784 | $74.08 | $370,400 | View SEC filing | |
| 2026-05-28 | Blum Robert I President & CEO | Sale | -7,500 | -1.87%392,830 | $77.21 | $579,075 | View SEC filing | |
| 2026-05-20 | Malik Fady Ibraham EVP Research & Development | Sale | -3,500 | -2.22%153,902 | $75.69 | $264,915 | View SEC filing | |
| 2026-05-14 | Blum Robert I President & CEO | Sale | -7,500 | -1.84%400,330 | $77.92 | $584,400 | View SEC filing | |
| 2026-05-05 | Malik Fady Ibraham EVP Research & Development | Sale | -3,500 | -2.22%153,902 | $77.37 | $270,795 | View SEC filing | |
| 2026-05-05 | WIERENGA WENDELL Director | Sale | -4,032 | -11.00%32,637 | $75.00 | $302,400 | View SEC filing | |
| 2026-05-05 | Lee Sung EVP, Chief Financial Officer | Sale | -23,906 | -27.44%63,221 | $76.87 | $1,837,654 | View SEC filing | |
| 2026-05-05 | HENDERSON JOHN T Director | Sale | -20,000 | -21.00%75,237 | $75.97 | $1,519,400 | View SEC filing | |
| 2026-05-05 | Callos Andrew EVP, Chief Commercial Officer | Sale | -11,333 | -16.22%58,555 | $77.25 | $875,474 | View SEC filing | |
| 2026-05-04 | Callos Andrew EVP, Chief Commercial Officer | Sale | -15,857 | -21.31%58,555 | $65.00 | $1,030,705 | View SEC filing | |
| 2026-04-30 | Callos Andrew EVP, Chief Commercial Officer | Sale | -15,000 | -20.39%58,555 | $63.26 | $948,900 | View SEC filing | |
| 2026-04-29 | Blum Robert I President & CEO | Sale | -7,500 | -1.81%407,830 | $59.62 | $447,150 | View SEC filing | |
| 2026-04-21 | Malik Fady Ibraham EVP Research & Development | Sale | -3,500 | -2.22%153,902 | $65.69 | $229,915 | View SEC filing | |
| 2026-04-15 | Callos Andrew EVP, Chief Commercial Officer | Sale | -7,449 | -11.29%58,555 | $66.02 | $491,783 | View SEC filing | |
| 2026-04-15 | Blum Robert I President & CEO | Sale | -7,500 | -1.77%415,330 | $65.38 | $490,350 | View SEC filing | |
| 2026-04-08 | Malik Fady Ibraham EVP Research & Development | Sale | -4,500 | -2.22%153,902 | $65.11 | $292,985 | View SEC filing | |
| 2026-04-01 | Blum Robert I President & CEO | Sale | -7,500 | -1.74%422,830 | $66.63 | $499,725 | View SEC filing | |
| 2026-03-31 | Callos Andrew EVP, Chief Commercial Officer | Sale | -3,639 | -5.23%66,004 | $65.00 | $236,535 | View SEC filing | |
| 2026-03-18 | Lee Sung EVP, Chief Financial Officer | Sale | -4,935 | -5.36%87,127 | $62.15 | $306,710 | View SEC filing | |
| 2026-03-18 | Callos Andrew EVP, Chief Commercial Officer | Sale | -8,542 | -10.66%71,573 | $62.15 | $530,885 | View SEC filing | |
| 2026-03-18 | Malik Fady Ibraham EVP Research & Development | Sale | -12,033 | -7.25%153,902 | $62.15 | $747,851 | View SEC filing |
1-25 of 624
